Correlation Between Actinogen Medical and TTG Fintech

Can any of the company-specific risk be diversified away by investing in both Actinogen Medical and TTG Fintech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinogen Medical and TTG Fintech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Actinogen Medical and TTG Fintech, you can compare the effects of market volatilities on Actinogen Medical and TTG Fintech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinogen Medical with a short position of TTG Fintech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinogen Medical and TTG Fintech.

Diversification Opportunities for Actinogen Medical and TTG Fintech

-0.44

Correlation Coefficient

Actinogen Medical  TTG Fintech

Very good diversification

The 3 months correlation between Actinogen and TTG is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Actinogen Medical and TTG Fintech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TTG Fintech and Actinogen Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinogen Medical are associated (or correlated) with TTG Fintech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TTG Fintech has no effect on the direction of Actinogen Medical i.e., Actinogen Medical and TTG Fintech go up and down completely randomly.

Pair Corralation between Actinogen Medical and TTG Fintech

Assuming the 90 days trading horizon Actinogen Medical is expected to generate 0.56 times more return on investment than TTG Fintech. However, Actinogen Medical is 1.8 times less risky than TTG Fintech. It trades about 0.11 of its potential returns per unit of risk. TTG Fintech is currently generating about -0.07 per unit of risk. If you would invest  2.60  in Actinogen Medical on December 30, 2024 and sell it today you would earn a total of  0.90  from holding Actinogen Medical or generate 34.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Actinogen Medical  vs.  TTG Fintech

Actinogen Medical

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Actinogen Medical are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Actinogen Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

TTG Fintech

Risk-Adjusted Performance

Very Weak

Over the last 90 days TTG Fintech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Actinogen Medical and TTG Fintech

The main advantage of trading using opposite Actinogen Medical and TTG Fintech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinogen Medical position performs unexpectedly, TTG Fintech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTG Fintech will offset losses from the drop in TTG Fintech's long position.

The idea behind Actinogen Medical and TTG Fintech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.